Publikationen von Petra Belcredi

Hampel, R.; Rueckerl, R.; Yli-Tuomi, T.; Breitner, S.; Lanki, T.; Kraus, U.; Cyrys, J.; Belcredi, P.; Belcredi, P.; Brueske, I. et al.; Laitinen, T. M.; Timonen, K.; Wichmann, H. -.; Peters, A.; Schneider, A.: Impact of personally measured pollutants on cardiac function. INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH 217 (4-5), S. 460 - 464 (2014)

Ising, M.; Scheuer, S.; Belcredi, P.; Uhr, M.; Holsboer, F.: Perspective of Personalized Drug Treatment in Depression. 73rd Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry (SOBP), New York, NY, 10. Mai 2018 - 12. Mai 2018. BIOLOGICAL PSYCHIATRY 83 (9, Suppl.), S74, S. S375 - S376 (2018)

Ising, M.; Belcredi, P.; Lucae, S.; Tontsch, A.; Namendorf, C.; Uhr, M.; Holsboer, F.; Rex-Haffner, M.; Simulionyte, E.; Hebib, S. et al.; Gruber Oliver, O.; Behler, N.; Nenov-Matt, T.; Schuele, C.; Manook, A.; Heckel, B.; Baghai, T.; Rupprecht, R.: GENOMIC AND IMMUNOLOGICAL BIOMARKERS FOR PREDICTING TREATMENT OUTCOME IN DEPRESSION. In INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 28, S. i314 - i314. (2025)

Ising, M.; Scheuer, S.; Belcredi, P.; Uhr, M.; Holsboer, F.: Perspective of personalised drug treatment in depression. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 29, S. S46 - S47. 31st Congress of the European-College-of-Neuropsychopharmacology (ECNP), Barcelona, SPAIN, 06. Oktober 2018 - 09. Oktober 2018. (2019)